Firefly Bio

“emerged from stealth with a $20 million Series A led by Definition Capital.”

“Johnson & Johnson agreed to buy Firefly Bio, an SF-based biotech focused on protein degraders, for $1b in cash.”

“Johnson & Johnson agreed to buy Firefly Bio, an SF-based biotech focused on protein degraders, for $1b in cash.”